Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Oncolytics Biotech buy Maxim Group

Start price
€1.61
10.03.25 / 50%
Target price
€2.76
10.03.26
Performance (%)
-
End price
-
11.03.26
Summary
This prediction was cancelled by the user.
Performance without dividends (%)
Name 1w 1m 1y
Oncolytics Biotech - - -
iShares Core DAX® 1.604% -7.448% 3.039%
iShares Nasdaq 100 -0.734% -1.864% 15.425%
iShares Nikkei 225® 1.296% -6.795% 34.306%
iShares S&P 500 -0.394% -2.336% 9.907%

Comments by Maxim_Group for this prediction

In the thread Oncolytics Biotech diskutieren
Prediction Buy
Perf. (%) -
Target price 2.761
Change
Ends at 10.03.26

Oncolytics Biotech Inc. (NASDAQ: ONCY) had its price target lowered by analysts at Maxim Group from $5.00 to $3.00. They now have a "buy" rating on the stock.
Ratings data for ONCY provided by MarketBeat

In the thread Trading Oncolytics Biotech
Prediction Buy
Perf. (%) -
Target price 2.761
Change
Ends at 10.03.26

Die von Maxim_Group gewählte maximale Laufzeit wurde überschritten